Linola

Urea, the active ingredient in Linola, is a keratolytic presented as a topical formulation for skin application. It helps to soften and hydrate dry, hyperkeratotic skin and is used in conditions such as dry skin, ichthyosis, hyperkeratosis and eczema in adults and children as appropriate.

GNH USA supplies Linola as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions across global markets.

Linola (urea) is a keratolytic used to manage disorders characterized by dry or hyperkeratotic skin.

- Dry skin: improves skin hydration and reduces scaling. - Ichthyosis: helps normalize the skin barrier and decrease roughness. - Hyperkeratosis: facilitates desquamation of thickened skin layers. - Eczema: alleviates dryness and supports barrier repair.

Topical urea is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild skin irritation: transient redness or tingling at the application site. - Itching: occasional pruritus during early use. - Dryness or peeling: temporary flaking as the skin adjusts.

Serious or Rare Side Effects: - Allergic contact dermatitis: swelling, blistering, or severe rash. - Severe skin irritation: persistent burning or pain requiring medical attention. - Secondary infection: signs of infection such as pus or increased warmth.

Before using Linola, consider the following safety measures.

- Avoid application on broken skin: may increase irritation. - Do not use with other strong keratolytics without medical advice: risk of excessive irritation. - Limit exposure to eyes: avoid contact and rinse thoroughly if accidental. - Discontinue if severe irritation occurs: seek medical advice promptly. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Topical urea may interact with certain skin products; monitor accordingly.

Major Interactions (Avoid): - Concurrent use with strong topical steroids: may increase skin thinning. - Combination with other keratolytics (e.g., salicylic acid): risk of excessive irritation. - Use with occlusive dressings: may enhance systemic absorption.

Moderate Interactions (Monitor Closely): - Use with moisturizers: generally safe but watch for additive irritation. - Use with topical antibiotics: monitor for allergic reactions. - Use with cosmetic products containing fragrances: may increase sensitization risk.